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RESUMO
A síndrome de enfalopatia posterior reversível é uma síndrome neurológica caracterizada por cefaleias, confusão, alterações visuais 
e convulsões associada a áreas de edema cerebral identificável em exames de neuroimagem. Os autores relatam o caso de um 
homem, 33 anos, leucodérmico, com história de alcoolismo e tabagismo crónico, que recorre ao serviço de urgência por epigastralgia 
em cinturão e vómitos com cerca de seis horas de evolução e cefaleia holocraneana intensa há duas horas. Ao exame objectivo, apre-
sentava tensão arterial de 190/100 mmHg e empastamento no epigastro. Analiticamente, amilase 193 U/L e lipase 934 U/L. Durante a 
observação no serviço de urgência, apresentou uma crise tónico-clónica generalizada. A ecografia abdominal realizada foi sugestiva 
de pancreatite, sem sinais de litíase biliar. A tomografia computorizada crânio-encefálica demonstrou hemorragia subaracnoideia e 
pequena hemorragia cortical frontal direita. A ressonância magnética nuclear crânio-encefálica realizada uma semana após a admis-
são revelou áreas de hipersinal T2/FLAIR bilaterais e simétricas na substância branca subcortical das regiões parietais e frontais 
superiores, sugerindo o diagnóstico de síndrome de enfalopatia posterior reversível. Na tomografia computorizada abdominal (10 dias 
após a admissão) visualizou-se pâncreas espessado, em relação com processo inflamatório e dois pequenos focos hipodensos na 
parte anterior do corpo, traduzindo pequenos focos de necrose. A investigação de defeitos trombofílicos revelou uma mutação do gene 
G20210A da protrombina em heterozigotia. O doente teve alta sem sequelas neurológicas, e assintomático. A ressonância magnética 
nuclear crânio-encefálica de controlo confirmou a reversão das lesões, confirmando o diagnóstico.
Palavras-chave: Alcoolismo/complicações; Edema Cerebral; Pancreatite Alcoólica; Síndrome de Enfalopatia Posterior Reversível.
ABSTRACT
The posterior reversible encephalopathy syndrome is a neurological syndrome characterized by headache, confusion, visual 
disturbances and seizures associated with identifiable areas of cerebral edema on imaging studies. The authors report the case 
of a man, 33 years-old, leukodermic with a history of chronic alcohol and tobacco consumption, who is admitted to the emergency 
department for epigastric pain radiating to the back and vomiting with about six hours of evolution and an intense holocranial headache 
for two hours. His physical examination was remarkable for a blood pressure of 190/100 mmHg and tenderness in epigastrium. His 
analytical results revealed emphasis on amylase 193 U/L and lipase 934 U/L. During the observation in the emergency department, 
he presented a generalized tonic-clonic seizure. Abdominal ultrasonography was performed and suggestive of pancreatitis without 
gallstones signals. Head computed tomography showed subarachnoid haemorrhage and a small right frontal cortical haemorrhage. 
The brain magnetic resonance imaging done one week after admission showed areas of a bilateral and symmetrical T2 / FLAIR 
hyperintensities in the subcortical white matter of the parietal and superior frontal regions, suggesting a diagnosis of posterior reversible 
encephalopathy syndrome. Abdominal computed tomography (10 days after admission) demonstrated a thickened pancreas in 
connection with inflammation and two small hypodense foci in the anterior part of the pancreas body, translating small foci of necrosis. 
The investigation of a thrombophilic defect revealed a heterozygous G20210A prothrombin gene mutation. The patient was discharged 
without neurological sequelae and asymptomatic. The follow-up brain magnetic resonance imaging confirmed the reversal of the 
lesions, confirming the diagnosis.
Keywords: Alcoholism/complications; Brain Edema; Pancreatitis, Alcoholic; Posterior Leukoencephalopathy Syndrome.
INTRODUCTION
 Originally named in a 1996 case series, the reversible 
posterior leukoencephalopathy syndrome or posterior re-
versible encephalopathy syndrome (PRES) is character-
ized by the clinical findings of headache, altered mental 
functioning, seizures, and loss of vision associated with 
symmetric and bilateral cerebral edema, most commonly in 
the occipito-parietal regions, on the neuroimaging studies.1 
Several conditions have been associated with PRES. The 
most well-documented are hypertension, eclampsia and 
immunosuppressive therapy. There is also a frequent as-
sociation with cytotoxic treatments, autoimmune diseases 
and infection/sepsis.2 There are as well numerous associa-
tions rarely or anecdotally reported. In the context of acute 
pancreatitis there have been reported only eight cases,3-10 
six of them available on PubMed/MEDLINE database.3-5, 7-9 
With early diagnosis and prompt treatment, the syndrome is 
usually fully reversible.2
CLINICAL FINDINGS
 The subject of this report is a 33-year-old leukodermic 
male, single, born and resident in Funchal, Madeira Island 
and employed as a construction worker. He disclosed 
a history of chronic alcoholism with an approximate 
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and about 150 g of alcohol per day in the weekend. He 
was an active tobacco smoker with a chronic consumption 
of 10 pack-year units and smoked cannabis about twice 
per month, denying any other history of drug use. He 
had no chronic medication and no drug or food allergies. 
No other personal relevant background was found. As 
family history is concerned, his mother had a diagnosis 
of arterial hypertension, currently controlled with chronic 
medication and his father was diagnosed with colorectal 
adenocarcinoma at 57 years-old.
 The patient presented to the emergency department 
(ED) of our hospital in August 2015 with an epigastric pain 
with dorsal irradiation, with an intensity 8/10 of sudden onset 
and with six hours of evolution. He complained of nausea 
and vomit starting a few minutes after the abdominal pain 
and a holocranial intense headache with two hours of 
evolution and progressive worsening.
 On physical examination he was confused but 
cooperative, with a Glasgow coma scale (GCS) of 14 
(E4V4M6). His temperature was 36.4ºC, blood pressure of 
190/100 mmHg, heart rate (HR) of 54 beats per minute (bpm) 
and a respiratory rate (RR) of 24 cycles per minute (cpm) 
at room air with SpO2 (peripheral oxygen saturation) of 
99%. Auscultation revealed no abnormalities. In abdominal 
examination, bowel sounds were absent and tenderness in 
epigastrium was evident; there was pain on pressuring the 
epigastrium but no signs of peritoneal irritation.
 While on observation, he had a generalized tonic-clonic 
seizure that lasted about 30 seconds, resolving immediately 
after the injection of 10 mg of intravenous (IV) diazepam. 
Likewise, 500 mg of phenytoin were infused. In the first 24 
hours, another two tonic-clonic seizures were documented.
DIAGNOSTIC FOCUS AND ASSESSMENT
 Complete blood count revealed leucocytosis (24,000/
µL) with neutrophilia (91.6%), a normal haemoglobin and 
platelet count. Blood chemistry confirmed elevation of 
serum amylase (193 U/L; reference range (RR): < 46 U/L), 
lipase (934 U/L; RR: < 51) and glucose (156 mg/dL). The 
levels of liver transaminases, bilirubin, urea, creatinine, 
lactate dehydrogenase (LDH) and C-reactive protein (CRP) 
were normal.
 After the first seizure, he was supplemented with 
oxygen and an arterial blood gas analysis was done (at 
FiO2 40%) that revealed a severe metabolic acidemia with 
hyperlactacidemia and hypokalemia (pH 6.98, pCO2 41 
mmHg, pO2 235 mmHg, HCO3 - 10.5 mmol/L, lactate 18 
mmol/L).
 The chest radiography showed no abnormalities. 
The abdominal ultrasound revealed a decreased diffuse 
parenchymal echogenicity of the pancreas and pancreatic 
body thickening, compatible with edema which correlates 
with pancreatitis; there were no signs of gallstones.
 The initial head CT (Fig. 1) revealed a small acute 
lobar haemorrhage in the right frontal lobe associated with 
a minor amount of blood in the surrounding cortical sulci. 
The MRI of the brain (Fig. 2), performed seven days later, 
showed a slight increase in the dimensions of the right 
frontal lobe subacute haemorrhage and of the surrounding 
edema but without significant mass effect. There were also 
 
Figure 1 – Initial CT scan showing an acute hematoma in the right 
frontal lobe and small amount of blood in the adjacent subarachnoid 
space
 
Figure 2 – Initial MRI scan (7 days). Axial T2-FLAIR images 
revealing bilateral and symmetric subcortical hyperintensities on 
the parietal lobes. There is also a slight growth of the subacute 
hemorrhage in the right frontal lobe.









Revista Científica da Ordem dos Médicos          www.actamedicaportuguesa.com                                                                                                                569
bilateral and symmetric T2/FLAIR hyperintense lesions in 
the subcortical white matter of the parietal and frontal lobes, 
without diffusion restriction, contrast enhancement or mass 
effect, suggesting posterior reversible encephalopathy 
syndrome (PRES).
 According to the revised Atlanta classification system, the 
acute pancreatitis was classified as interstitial edematous 
and moderately severe. The Acute Physiology and Chronic 
Health Evaluation II (APACHE II) score was 17 points and 
the Bedside Index for Severity in Acute Pancreatitis (BISAP) 
score was three points.
 Consequently, the patient was admitted to the Intensive 
Care Unit (ICU).
THERAPEUTIC FOCUS AND ASSESSMENT
 Our patient was treated with supportive care: nil per os 
was instituted and the patient started vigorous IV hydration 
with normal saline and lactated Ringer’s solution; analgesia 
with pethidine; anti-hypertensive therapy with IV clonidine 
titrated according the blood pressure; and anti-convulsive 
with IV phenytoin. 
 After 24 hours, the blood pressure had stabilized around 
140 mmHg systolic and 90 mmHg diastolic, the mental 
status improved, and neither neurological deficits nor 
symptoms of alcohol withdrawal were present (IV tiapride 
and thiamine was administered daily from admission due to 
his regular heavy alcohol consumption). Sinus bradycardia 
was observed but it resolved after phenytoin was withdrawn 
and levetiracetam added. Although bilateral pleural effusion 
was evident on plain chest radiographs there were no acute 
distress respiratory syndrome radiologic signs. On the third 
day, enteric nutrition was initiated and the IV hydration and 
analgesia were abridged, and oxygen supplementation was 
suspended.
 Once stable, the patient was transferred to the 
gastroenterology nursery. He resumed oral feeding on the 
sixth day of hospitalization. 
 Several exams failed to demonstrate a secondary 
cause to his arterial hypertension: adrenocorticotropic 
hormone 23.3 pg/mL (RR: 7.2 – 63.3), aldosterone 2.95 
ng/dL (RR: 1.00 – 16.0), free thyroxine 1.1 ng/dL (RR: 0.6 
– 1.7), thyroid-stimulating hormone 1.93 µUI/mL (RR: 0.3 
– 4.7), renin 0.5 pg/mL, antinuclear and antiphospholipid 
antibodies were absent, C4 and C3 weren’t consumed, 
plasmatic and urinary levels of vanillylmandelic acid, 
catecholamines and metanephrines were low. Thoracic and 
abdominal contrast enhanced computerized tomography 
and abdominal ultrasound with Doppler study did not show 
any signs of coarctation of the aorta, renal artery stenosis, 
structural abnormalities of kidneys, or tumours.
 The investigation of a thrombophilic defect, done three 
months after the acute event, revealed a heterozygous 
G20210A prothrombin gene mutation. The remaining 
tests including protein C, protein S, activated protein C 
resistance, antithrombin, lupic anticoagulant and FV Leiden 
mutation (G1291A) revealed no abnormalities.
 Abdominal CT (10 days after admission) demonstrated 
a thickened pancreas in connection with inflammation and 
two small hypodense foci (9 and 6 mm) in the anterior part 
of the pancreas body, translating small foci of necrosis. 
There were no other signs of local complications. The liver 
was slightly enlarged but with normal density and outline, 
without nodules.
FOLLOW-UP AND OUTCOMES
 The patient was discharged on the fifteenth day. It was 
prescribed levetiracetam 3 g/day and clonidine 0.3 mg/day. 
He had psychological support for the withdrawal of alcohol, 
tobacco and cannabis. The ambulatory blood pressure 
remained stable at 130 mmHg systolic and 80 mmHg 
diastolic. There were neither new seizures nor neurologic 
deficits. Clonidine was weaned off while perindopril 5 mg 
was introduced. 
 The follow-up MRI, done two months later, revealed 
signs of reabsorption of the right frontal lobe haemorrhage 
and also complete disappearance of the subcortical white 
matter lesions, confirming the diagnosis of PRES (Fig. 3).
DISCUSSION
 The PRES is an increasingly recognized and reported 
entity but its incidence is still unknown and the list of 
possible associated conditions is growing. To the extent of 
our knowledge, we report the ninth case of PRES described 
in the context of acute pancreatitis3-10 (six reported in the 
MEDLINE database).3-5,7-9 From the analysis of the previous 
clinical cases, five of the eight reported cases had at least 
one comorbid medical condition that has been implicated 
as a cause of PRES besides acute pancreatitis (AP).3-5,7-8 
(Table 1) There are, however, three reports of AP due to 
 
Figure 3 – Follow-up MRI scan (2 months).  Axial T2-FLAIR images 
with complete reversal of the subcortical white matter changes and 
reabsorption of the lobar hematoma. 
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alcohol consumption, without any other active comorbidity, 
that developed PRES.6,9-10
 Our patient was severely hypertensive at presentation 
and the evolution of his hemodynamic profile revealed a 
hypertension difficult to control and the need for chronic 
medication after hospital discharge. Notwithstanding, 
we highlight that the symptoms of AP started before 
the symptomatology of PRES and we believe that the 
pro-inflammatory cytokines released contributed to its 
pathogenesis. There is a study in rats demonstrating that 
these cytokines (TNF and IL-6 released after AP) damage 
the blood-brain barrier (BBB) and are sufficient to cause 
leakage of blood to the cerebral tissue, causing vasogenic 
brain edema formation, as seen in PRES.11 In humans, 
the reports are yet scarce, but it seems that in most cases 
there is a need of an additional factor to cause PRES in 
acute pancreatitis cases (as demonstrated in Table 1). 
Another question to be answered in future reports is the 
relationship between the severity of pancreatitis and the 
possibility of developing PRES. In our case, the patient had 
a moderately severe to severe pancreatitis (depending on 
the classification used) but in most cases this data is not 
referred and there is insufficient data to classify.
 There are also three reports of PRES in patients with acute 
alcohol withdrawal without other comorbidities reported and 
without any evidence of pancreatitis.12-14 In fact, an in vitro 
study has demonstrated that the oxidative stress resulting 
from alcohol metabolism in brain microvascular endothelial 
cells can lead to BBB breakdown in alcohol abuse, serving 
as an aggravating factor in neuroinflammatory disorders.15 
We did not measure the serum level of ethanol, but the 
patient had recently consumed about 100 g of alcohol. 
The patient had no signs or symptoms of acute alcohol 
withdrawal but was medicated with benzodiazepines for 
control of his seizures and tiapride. One of these three 
cases reports the blood alcohol level which was very 





Diagnosis or condition 
associated
Clinical findings Lesions on 1st MRI Follow-up MRI









Bilateral T2 hyperintense 
lesions in the O and C and in 
the posterior limb of the right 
internal capsule
4 weeks: normal






hyperintense lesions in the 
bilateral Fr, P and O
6 weeks: normal





Bilateral T2 hyperintense 
lesions in the P and O
2 months: normal





hyperintense lesions in the 
P and Fr (bilateral) and 
subcortical lesions in the left 
O and T
Day 16: normal
20147 19 / F Phospholipid antibody 
syndrome, acute 




Bilateral T2 hyperintense 
lesions in the C, P and Fr
Normal (time 
unspecified)
20148 18 / M Monocytic leukaemia, 






Bilateral T2 hyperintense 
lesions in the subcortical and 




20159 49 / M Chronic alcoholism Confusion and 
disorientation
Corticosubcortical T2 
hyperintense lesions in both 
the P, T and O, and in the 
left C
1 month: a few 
microbleeds in 
the left C
201510 40 / F Alcohol intake Sudden visual loss Bilateral T2 hyperintense 
lesions in the P, O and C
No reference
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high (358 mg/dl). The other two make no reference to it, 
but the anecdotal association could mean that a very high 
level must be present for PRES to occur without any other 
predisposing factor.
 To the extent of our knowledge, this is also the 
first documented case of PRES in a patient who is a 
heterozygous carrier of the G20210A prothrombin gene 
mutation. This mutation is an identified congenital risk factor 
for venous thrombosis but its role in arterial thrombosis is 
not clear. However, a relation to stroke in younger patients 
has been suggested. Since the prevalence of the mutation 
in the general population of southern Europe is about 3%, 
and twice as high as the prevalence in northern Europe, it is 
not possible to make any casual or risk inference based in 
just this finding. Nevertheless, we highlight that one of the 
case reports of PRES in the context of acute pancreatitis 
occurred in a patient with phospholipid antibody syndrome.7 
Therefore, the role of inherited or acquired thrombophilic 
defects in PRES needs to be further explored.
 As other authors have previously suggested,5,9 we 
propose that acute pancreatitis might complicate, or even, 
cause PRES. The main pathogenic mechanism would be the 
damage of the blood-brain barrier by the pro-inflammatory 
cytokines released. Alcohol might be another important 
aggravating or causative factor.
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